Friday, February 1, 2013

• One Person's Trash Is Another Person's Treasure Portfolioat Motley Fool (Fri, Feb 1)
• Investors Discounting Positive Data Readout On Brain Cancer Studiesat Seeking Alpha (Fri, Feb 1)

Thursday, January 31, 2013

• Dendreon's Provenge still facing headwinds, says RW Bairdat theflyonthewall.com (Thu, Jan 31)

Wednesday, January 30, 2013

• This Just In: Upgrades and Downgradesat Motley Fool (Wed, Jan 30)
• Dendreon to Host Conference Call on February 25 to Announce Fourth Quarter and Full Year 2012 Financial Results and Webcast Presentations at Upcoming ConferencesBusiness Wire (Wed, Jan 30)

Monday, January 28, 2013

• Dendreon Corp (DNDN): Today's Featured Drugs Winnerat TheStreet (Mon, Jan 28)
• Dendreon's Provenge: Update With The President Of The Large Urology Group Practice Associationat Seeking Alpha (Mon, Jan 28)
• Seeking Alpha Author Used Multiple Aliases to Tout Biotech Stocksat TheStreet (Mon, Jan 28)

Sunday, January 27, 2013

• Here's a Basket of Potentially Explosive Growthat Motley Fool (Sun, Jan 27)
• 2 Biotech Stocks To Buy Right Nowat Seeking Alpha (Sun, Jan 27)

Wednesday, January 23, 2013

• Could Dendreon Be a Buyout Candidate?at Motley Fool (Wed, Jan 23)
• Three Reasons Delcath Systems Appears Undervaluedat Seeking Alpha (Wed, Jan 23)
• 2 Biotech Champions For 2013at Seeking Alpha (Wed, Jan 23)
• This Just In: Upgrades and Downgradesat Motley Fool (Wed, Jan 23)

Tuesday, January 22, 2013

• Prostate cancer vaccine developer loses chief executiveat bizjournals.com (Tue, Jan 22)

Monday, January 21, 2013

• JNJ Looks Good, But Is There Enough Momentum?at Motley Fool (Mon, Jan 21)

Sunday, January 20, 2013

• Dendreon's Critical Clinical Trialsat Motley Fool (Sun, Jan 20)
• This Just In: Upgrades and Downgradesat Motley Fool (Sun, Jan 20)

Saturday, January 19, 2013

• Dendreon's Secret Silver Liningat Motley Fool (Sat, Jan 19)

Friday, January 18, 2013

• The New Biotech Media Blitzat Motley Fool (Fri, Jan 18)
• Biotech Stock Mailbag: Peregrine, Arena, Dendreon, NPS Pharmaat TheStreet (Fri, Jan 18)

Wednesday, January 16, 2013

• Five High-Profile Stocks Moving Higherat Motley Fool (Wed, Jan 16)
• 2 Biotech Winners For 2013at Seeking Alpha (Wed, Jan 16)
• Dendreon's Big New Pushat Motley Fool (Wed, Jan 16)
• Is the Optimism Surrounding Provenge Reason to Buy?at Motley Fool (Wed, Jan 16)

Add DNDN News to My Yahoo!